Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences

Arun Sankaradoss, Suraj Jagtap, Junaid Nazir, Shefta E-Moula, Ayan Modak, Joshuah Fialho, Meenakshi Iyer, Jayanthi S Shastri, Mary Dias, Ravisekhar Gadepalli, Alisha Aggarwal, Manoj Vedpathak, Sachee Agrawal, Awadhesh Pandit, Amul Nisheetha, Anuj Kumar, Mohamed Shafi, Swathi Balachandra, Tina Damodar, Moses Muia Masika, Patrick Mwaura, Omu Anzala, Kar Muthumani, Ramanathan Sowdhamini, View ORCID ProfileGuruprasad R. Medigeshi, Rahul Roy, Chitra Pattabiraman, Sudhir Krishna, Easwaran Sreekumar
doi: https://doi.org/10.1101/2021.09.21.21263883
Arun Sankaradoss
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arunsankaradoss@gmail.com esreekumar@rgcb.res.in
Suraj Jagtap
2Department of Chemical Engineering, Indian Institute of Science, Bangalore, 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junaid Nazir
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shefta E-Moula
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayan Modak
3Molecular Virology Laboratory, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, 695014, Kerala, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshuah Fialho
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meenakshi Iyer
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jayanthi S Shastri
4Department of Microbiology, T.N.Medical College & B.y.L.Nair Hospital, Mumbai, 400008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Dias
5Division of Infectious disease, St.John’s Medical College and Hospital, Bangalore, 560034, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravisekhar Gadepalli
6Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, 342005, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alisha Aggarwal
6Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, 342005, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manoj Vedpathak
4Department of Microbiology, T.N.Medical College & B.y.L.Nair Hospital, Mumbai, 400008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sachee Agrawal
4Department of Microbiology, T.N.Medical College & B.y.L.Nair Hospital, Mumbai, 400008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Awadhesh Pandit
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amul Nisheetha
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anuj Kumar
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Shafi
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swathi Balachandra
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Damodar
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moses Muia Masika
7KAVI Institute of Clinical Research, University of Nairobi, Nairobi, 19676-00202, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Mwaura
7KAVI Institute of Clinical Research, University of Nairobi, Nairobi, 19676-00202, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omu Anzala
7KAVI Institute of Clinical Research, University of Nairobi, Nairobi, 19676-00202, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kar Muthumani
8Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA 19104, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramanathan Sowdhamini
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guruprasad R. Medigeshi
9Translational Health Science and Technology Institute, Faridabad, Haryana, 121001, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guruprasad R. Medigeshi
Rahul Roy
10Department of Chemical Engineering, Indian Institute of Science, Bangalore, India; Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India; Center for Biosystems Science and Engineering, Indian Institute of Science, Bangalore, 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chitra Pattabiraman
11Department of Neurovirology, National Institute of Mental Health and Neurosciences, Bangalore, 560029, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudhir Krishna
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, 560065, India
12School of Interdisciplinary Life Sciences, Indian Institute of Technology Goa, Ponda, 404401, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Easwaran Sreekumar
3Molecular Virology Laboratory, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, 695014, Kerala, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arunsankaradoss@gmail.com esreekumar@rgcb.res.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Following the recent clinical clearance of an Indian DNA COVID-19 vaccine, India and Africa are potential regions where DNA vaccines may become a major delivery system subject to a range of immunological and regulatory scrutiny. The ongoing COVID pandemic highlights the need to tackle viral variants and expand the number of antigens and assess diverse delivery systems. To address some of these key issues, we have created a Dengue DNA vaccine candidate with the EDIII region as the key antigen given the promise of this segment in not causing ADE, a challenge with this disease. In addition, we have added the NS1 region to broaden the immune response. Following a large Dengue viral sequencing exercise in India, complemented with data from east Africa, our approach was to generate a consensus of four serotypes ED3-NS1 vaccine to explore tackling the issue of diversity. Our In silico structural analysis of EDIII consensus vaccine sequence revealed that epitopes are structurally conserved and immunogenic across HLA diversity. Vaccination of mice with this construct induced pan-serotype neutralizing antibodies and antigen-specific T cell responses. Furthermore, the DNA vaccination confers protection against DENV challenge in AG129 mice. Finally, assaying of intracellular staining for IFN-γ, immunoglobulin IgG2(a/c) /IgG1 ratios as well as immune gene profiling suggested a strong Th1-dominant immune response. Our Dengue DNA platform with a focus on Indo-African sequences offers an approach for assessing cross reactive immunity in animal models and lays the foundation for human vaccine roll out either as a stand-alone or mix and match strategy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by philanthropist Mr. Narayana Murthy, Co-founder of Infosys, NCBS/TIFR, DBT to SK, RGCB (Intramural grant) to ES, and TRC-BIRAC grant to GM. The sponsors of the study had no role in study design, sample collection, data collection, data analysis, data interpretation, or writing of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Ethical Clearance Review Boards approved the study of all institutions participating in this study (SJRI- IRB NO:-236/2016, AIIMS, Jodhpur-AIIMS/IEC/2017/49, & AIIMS/IEC/2019-20/939, KIH- IRB NO:07/2018, Ethics/THSTI/2011/2.1; AIIMS: IEC/NP:338/2011). The study was also approved by National Centre for Biological Sciences (NCBS) and Rajiv Gandhi Centre for Biotechnology (RGCB) Institutional Animal Ethics committee.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Whole Dengue virus genome sequences generated in the study have been deposited in the GenBank. The authors confirm that the data supporting the study findings are available within the manuscript and its supplementary figures and tables. Additional raw data supporting the findings of this study are available from the corresponding authors AS and ES on request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences
Arun Sankaradoss, Suraj Jagtap, Junaid Nazir, Shefta E-Moula, Ayan Modak, Joshuah Fialho, Meenakshi Iyer, Jayanthi S Shastri, Mary Dias, Ravisekhar Gadepalli, Alisha Aggarwal, Manoj Vedpathak, Sachee Agrawal, Awadhesh Pandit, Amul Nisheetha, Anuj Kumar, Mohamed Shafi, Swathi Balachandra, Tina Damodar, Moses Muia Masika, Patrick Mwaura, Omu Anzala, Kar Muthumani, Ramanathan Sowdhamini, Guruprasad R. Medigeshi, Rahul Roy, Chitra Pattabiraman, Sudhir Krishna, Easwaran Sreekumar
medRxiv 2021.09.21.21263883; doi: https://doi.org/10.1101/2021.09.21.21263883
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences
Arun Sankaradoss, Suraj Jagtap, Junaid Nazir, Shefta E-Moula, Ayan Modak, Joshuah Fialho, Meenakshi Iyer, Jayanthi S Shastri, Mary Dias, Ravisekhar Gadepalli, Alisha Aggarwal, Manoj Vedpathak, Sachee Agrawal, Awadhesh Pandit, Amul Nisheetha, Anuj Kumar, Mohamed Shafi, Swathi Balachandra, Tina Damodar, Moses Muia Masika, Patrick Mwaura, Omu Anzala, Kar Muthumani, Ramanathan Sowdhamini, Guruprasad R. Medigeshi, Rahul Roy, Chitra Pattabiraman, Sudhir Krishna, Easwaran Sreekumar
medRxiv 2021.09.21.21263883; doi: https://doi.org/10.1101/2021.09.21.21263883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1095)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9766)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1557)
  • Health Policy (734)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11639)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1175)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4654)
  • Radiology and Imaging (776)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)